Changeflow GovPing Healthcare Systems and Methods for Monitoring Efficacy of ...
Routine Notice Added Final

Systems and Methods for Monitoring Efficacy of Cytotoxic Treatment

Favicon for changeflow.com EPO Patent Bulletin - Health Informatics (G16H)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4500551A1 for Washington University, covering systems and methods for monitoring the efficacy of cytotoxic treatments. The patent application includes IPC classifications related to health informatics (G16H), pharmaceutical compositions (A61K), and genetic testing methods (C12Q). The designated contracting states include all major European Economic Area countries, granting Washington University exclusive intellectual property rights in Europe upon grant.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The EPO published patent application EP4500551A1, establishing Washington University's intellectual property rights in Europe for systems and methods of monitoring cytotoxic treatment efficacy. The application includes specific IPC classifications covering health informatics (G16H), pharmaceutical compositions (A61K), and genetic testing methods (C12Q). Designated contracting states include all major European Economic Area countries.

For companies developing diagnostic or monitoring systems for cancer treatments, this patent publication establishes prior art and may require freedom-to-operate analysis. Medical device manufacturers and healthcare providers utilizing similar technologies in Europe should assess potential infringement risks and consider licensing discussions with Washington University.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

SYSTEMS AND METHODS FOR MONITORING EFFICACY OF CYTOTOXIC TREATMENT

Publication EP4500551A1 Kind: A1 Apr 08, 2026

Applicants

Washington University

Inventors

CHAUDHURI, Aadel, ZEVALLOS, Jose

IPC Classifications

G16H 50/20 20180101AFI20260304BHEP A61K 9/127 20250101ALI20260304BHEP A61K 31/00 20060101ALI20260304BHEP C12Q 1/6886 20180101ALI20260304BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4500551A1

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent publication Medical device IP Healthcare technology
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!